Phase II evaluation of aclarubicin in lung cancer: a Southeastern Cancer Study Group Trial.

Published

Journal Article

Full Text

Duke Authors

Cited Authors

  • Kramer, BS; Birch, R; Gockerman, JP; Greco, A; Prestridge, K

Published Date

  • June 1, 1986

Published In

Volume / Issue

  • 70 / 6

Start / End Page

  • 803 - 804

PubMed ID

  • 3015404

Pubmed Central ID

  • 3015404

International Standard Serial Number (ISSN)

  • 0361-5960

Language

  • eng

Conference Location

  • United States